Underperforming Moderna Stock Boosted by Bird Flu Vaccine

Moderna Inc (NASDAQ:MRNA) stock is surging today, up 8.7% at $37.02 at last glance, after the vaccine maker was awarded$590 million from the U.S. Health and Human Services Department to speed up the development of its bird flu vaccine, as the virus spreads rapidly throughout the country. MRNA has had a rough go of it since its meteoric rise at the height of Covid-19, as the demand vaccines waned. Just last week, the stock plummeted to its lowest levels since 2020 after a slashed forecast. Since last Januar ...